Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12

NCT00194753 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm

Interventions

DRUG: Paclitaxel
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: G-CSF

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]